Find out more
The pre-filled syringe (PFS) market is experiencing rapid growth, having been valued at US $4.5 billion in 2022. Projections indicate that the global market will reach $5.53 billion by 2029, with a compound annual growth rate (CAGR) of 2.9 percent over the forecast period. Packaging is poised to play a pivotal role in driving the sector’s success in 2024 and beyond.
Anticipated innovations in PFS packaging design are expected to enter mainstream adoption to support advancements in various areas. These innovations encompass solutions aimed at enhancing usability for more convenient self-administration by patients, initiatives to ensure compliance with anti-counterfeiting legislation to bolster patient safety, and the introduction of new materials to promote sustainability.
Nevertheless, the adoption of new PFS packaging presents challenges for many pharmaceutical companies, especially smaller drug developers. The substantial capital expenditure required for upgrading manufacturing lines, coupled with the potential uncertainty surrounding the selection of suitable solutions tailored to treatment needs, can create daunting barriers to leveraging new technology.
In light of these challenges, establishing close partnerships with experts specializing in PFS packaging will be imperative for pharmaceutical companies seeking to thrive in 2024 and beyond.
Read the .
